The impact analysis also revealed the enrichment of the “Type II diabetes mellitus” pathway resulting from the upregulation of MAPK10 and IRS2 and the downregulation of CACNA1A and SOCS2, a signature that may upregulate the insulin receptor (INSR), PI3K, and insulin resistance. The gene discussed is IRS2; the disease is type 2 diabetes mellitus.